Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi In what would be an unprecedented move, the head of the Africa Centres for Disease Control and Prevention (Africa CDC) says the organization will “most likely” declare a Public Health Emergency of Continental Security (PHECS) this week because of the rapid […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi It’s rare for scientists to get a standing ovation for presenting their data. But after South African researcher Linda-Gail Bekker finished her talk about an HIV prevention trial at the AIDS 2024 conference in Munich last week, the audience stood up
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi There’s welcome news in the battle against the Ebola virus, an infectious disease that for years had almost no treatments or remedies. Outbreaks of the deadly Ebola virus flare up in parts of Africa almost every year, and they’re vicious. The
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The 2023 Nobel Prize in Physiology or Medicine has been jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 https://www.nobelprize.org/prizes/medicine/2023/press-release/ The discoveries by the two
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi To the relief of biomedical research advocates, a US Senate spending panel has approved a modest budget increase of 2% for the National Institutes of Health (NIH). The bump to $47.8 billion roughly matches President Joe Biden’s request for the 2024
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The pharmaceutical company Johnson & Johnson (J&J) in mid-July agreed to help make a therapy critical to fighting drug-resistant tuberculosis (TB) more widely available and affordable. J&J said it would allow competitors to market generic versions of the lifesaving drug, bedaquiline,
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years. The roll out is a critical step forward in the fight against one of the leading causes
In a packed San Francisco conference room last Tuesday, upbeat company representatives and scientists presented detailed clinical trial data on the first Alzheimer’s treatment shown to clearly, albeit modestly, slow the disease’s normal cognitive decline. The antibody therapy has buoyed a field marked by decades of failures. Now, it appears to be on the cusp
Potential new therapy for Alzheimer’s disease Read More »
The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class of therapies that break down or inhibit build up of amyloid plaques in the brain,
A new monoclonal antibody treatment for Alzheimer’s disease Read More »
Earlier this week, the pharmaceutical companies Biogen and Eisai announced encouraging results from a clinical trial for patients with Alzheimer’s disease: a monoclonal antibody treatment, called lecanemab, reduced cognitive decline by 27% in people with early-stage Alzheimer’s compared with those on a placebo after a year and a half. Outside observers say the trial could
Monoclonal antibody marks first approved Alzheimer’s treatment in nearly twenty years Read More »
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
